Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Verapamil Versus Metoprolol for Rate Control in Hemodynamically Stable Atrial Fibrillation With Rapid Ventricular Response
NCT07706075Phase 4Not yet recruiting
- Start
- Jan 2027
- Primary completion
- Jul 2027
01
Overview
Phase 4, randomised, single-blind trial in Atrial fibrillation (AFib) comparing Verapamil group with Metoprolol group (2 arms). Primary endpoint: Proportion of Participants Achieving Target Heart Rate Control Within 30 Minutes. Planned start Jan 2027; status: not yet recruiting.
02
Drugs
verapamilmetoprolol
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT07706075.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07706075.